The role of molecular imaging in detecting fibrosis in Crohn’s disease

References

• D’Haens G, Rieder F, Feagan BG, et al. Challenges in the pathophysiology, diagnosis, and management of intestinal fibrosis in inflammatory bowel disease. Gastroenterology. 2022;162(1):1–12. doi: 10.1053/j.gastro.2019.05.072.
   Web of Science ®Google Scholar
• Latella G, Di Gregorio J, Flati V, et al. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scand J Gastroenterol. 2015;50(1):53–65. doi: 10.3109/00365521.2014.968863.
   PubMed Web of Science ®Google Scholar
• Alfredsson J, Wick MJ. Mechanism of fibrosis and stricture formation in Crohn’s disease. Scand J Immunol. 2020;92(6):e12990. doi: 10.1111/sji.12990.
   PubMed Web of Science ®Google Scholar
• Lin X, Wang Y, Liu Z, et al. Intestinal strictures in crohn’s disease: a 2021 update. Therap Adv Gastroenterol. 2022;15:17562848221104951. doi: 10.1177/17562848221104951.
   Web of Science ®Google Scholar
• Wu X, Lin X, Tan J, et al. Cellular and molecular mechanisms of intestinal fibrosis. Gut Liver. 2023;17(3):360–374. doi: 10.5009/gnl220045.
   PubMed Web of Science ®Google Scholar
• Shaban N, Hoad CL, Naim I, et al. Imaging in inflammatory bowel disease: current and future perspectives. Frontline Gastroenterol. 2022;13(e1):e28–e34. doi: 10.1136/flgastro-2022-102117.
   PubMed Web of Science ®Google Scholar
• Waldner MJ, Rath T, Schürmann S, et al. Imaging of mucosal inflammation: current technological developments, clinical implications, and future perspectives. Front Immunol. 2017;8:1256. doi: 10.3389/fimmu.2017.01256.
   PubMed Web of Science ®Google Scholar
• Horsthuis K, Bipat S, Bennink RJ, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64–79. doi: 10.1148/radiol.2471070611.
   PubMed Web of Science ®Google Scholar
• Rieder F, Latella G, Magro F, et al. European Crohn’s and Colitis Organisation topical review on prediction, diagnosis and management of fibrostenosing Crohn’s disease. J Crohns Colitis. 2016;10(8):873–885. doi: 10.1093/ecco-jcc/jjw055.
   PubMed Web of Science ®Google Scholar
• Gordon IO, Bettenworth D, Bokemeyer A, et al. International consensus to standardise histopathological scoring for small bowel strictures in Crohn’s disease. Gut. 2022;71(3):479–486. doi: 10.1136/gutjnl-2021-324374.
   PubMed Web of Science ®Google Scholar
• De Voogd F, Mookhoek A, Gecse K, et al. Systematic review: histological scoring of strictures in crohn’s disease. J Crohns Colitis. 2020;14(6):734–742. doi: 10.1093/ecco-jcc/jjz177.
   PubMed Web of Science ®Google Scholar
• Foti PV, Travali M, Farina R, et al. Can conventional and diffusion-weighted mr enterography biomarkers differentiate inflammatory from fibrotic strictures in crohn’s disease? Medicina. 2021;57(3):265. doi: 10.3390/medicina57030265.
   PubMedGoogle Scholar
• Li X-h, Mao R, Huang S-y, et al. Ability of DWI to characterize bowel fibrosis depends on the degree of bowel inflammation. Eur Radiol. 2019;29(5):2465–2473. doi: 10.1007/s00330-018-5860-x.
   PubMed Web of Science ®Google Scholar
• Zhang M-C, Li X-H, Huang S-Y, et al. IVIM with fractional perfusion as a novel biomarker for detecting and grading intestinal fibrosis in Crohn’s disease. Eur Radiol. 2019;29(6):3069–3078. doi: 10.1007/s00330-018-5848-6.
   PubMed Web of Science ®Google Scholar
• Lu B, Lin J, Du J, et al. Native T 1 mapping and magnetization transfer imaging in grading bowel fibrosis in Crohn’s disease: a comparative animal study. Biosensors (Basel). 2021;11(9):302. doi: 10.3390/bios11090302.
   PubMedGoogle Scholar
• Adler J, Swanson SD, Schmiedlin-Ren P, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology. 2011;259(1):127–135. doi: 10.1148/radiol.10091648.
   PubMed Web of Science ®Google Scholar
• Dal Buono A, Faita F, Peyrin-Biroulet L, et al. Ultrasound elastography in inflammatory bowel diseases: a systematic review of accuracy compared with histopathological assessment. J Crohns Colitis. 2022;16(10):1637–1646. doi: 10.1093/ecco-jcc/jjac082.
   PubMed Web of Science ®Google Scholar
• Allocca M, Dal Buono A, D’Alessio S, et al. Relationships between intestinal ultrasound parameters and histopathologic findings in a prospective cohort of patients with crohn’s disease undergoing surgery. J of Ultrasound Medicine. 2023;42(8):1717–1728. doi: 10.1002/jum.16191.
   PubMed Web of Science ®Google Scholar
• Meng J, Mao Y, Zhou J, et al. Mesenteric abnormalities play an important role in grading intestinal fibrosis in patients with crohn’s disease: a computed tomography and clinical marker-based nomogram. Therap Adv Gastroenterol. 2022;15:17562848221122504. doi: 10.1177/17562848221122504.
   Web of Science ®Google Scholar
• Xu C, Jiang W, Wang L, et al. Intestinal ultrasound for differentiating fibrotic or inflammatory stenosis in Crohn’s disease: a systematic review and meta-analysis. J Crohns Colitis. 2022;16(9):1493–1504. doi: 10.1093/ecco-jcc/jjac052.
   PubMed Web of Science ®Google Scholar
• Allocca M, Fiorino G, Bonifacio C, et al. Noninvasive multimodal methods to differentiate inflamed vs fibrotic strictures in patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2019;17(12):2397–2415. doi: 10.1016/j.cgh.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Dillman JR, Swanson SD, Johnson LA, et al. Comparison of noncontrast MRI magnetization transfer and T2-weighted signal intensity ratios for detection of bowel wall fibrosis in a crohn’s disease animal model. J Magn Reson Imaging. 2015;42(3):801–810. doi: 10.1002/jmri.24815.
   PubMed Web of Science ®Google Scholar
• Li X-h, Mao R, Huang S-y, et al. Characterization of ­degree of intestinal fibrosis in patients with crohn disease by using magnetization transfer MR imaging. Radiology. 2018;287(2):494–503. doi: 10.1148/radiol.2017171221.
   PubMed Web of Science ®Google Scholar
• Meng J, Huang S, Sun C, et al. Comparison of three magnetization transfer ratio parameters for assessment of ­intestinal fibrosis in patients with Crohn’s disease. Korean J Radiol. 2020;21(3):290–297. doi: 10.3348/kjr.2019.0217.
   PubMed Web of Science ®Google Scholar
• Kim K-J, Lee Y, Park SH, et al. Diffusion-weighted MR enterography for evaluating crohn’s disease: how does it add diagnostically to conventional MR enterography? Inflamm Bowel Dis. 2015;21(1):101–109. doi: 10.1097/MIB.0000000000000222.
   PubMed Web of Science ®Google Scholar
• Tielbeek JA, Ziech ML, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24(3):619–629. doi: 10.1007/s00330-013-3015-7.
   PubMed Web of Science ®Google Scholar
• Rosenbaum DG, Rose ML, Solomon AB, et al. Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1075–1080. doi: 10.1007/s00261-015-0403-2.
   PubMedGoogle Scholar
• Kovanlikaya A, Beneck D, Rose M, et al. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn’s disease: preliminary experience. Abdom Imaging. 2015;40(5):1068–1074. doi: 10.1007/s00261-014-0247-1.
   PubMedGoogle Scholar
• Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease. Aliment Pharmacol Ther. 2018;48(3):347–357. doi: 10.1111/apt.14853.
   PubMed Web of Science ®Google Scholar
• Zalev J, Richards LM, Clingman BA, et al. Opto-acoustic imaging of relative blood oxygen saturation and total hemoglobin for breast cancer diagnosis. J Biomed Opt. 2019;24(12):1–16. doi: 10.1117/1.JBO.24.12.121915.
   Web of Science ®Google Scholar
• Eriksson O, Laughlin M, Brom M, et al. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use. Diabetologia. 2016;59(7):1340–1349. doi: 10.1007/s00125-016-3959-7.
   PubMed Web of Science ®Google Scholar
• Catalano O, Maccioni F, Lauri C, et al. Hybrid imaging in crohn’s disease: from SPECT/CT to PET/MR and new image interpretation criteria. AIMN)(IAR), Section of the Society of. 2017;62(1):40–55.
   Google Scholar
• Groshar D, Bernstine H, Stern D, et al. PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake. J Nucl Med. 2010;51(7):1009–1014. doi: 10.2967/jnumed.109.073130.
   PubMed Web of Science ®Google Scholar
• Pellino G, Nicolai E, Catalano OA, et al. PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel crohn’s disease. J Crohns Colitis. 2016;10(3):277–285. doi: 10.1093/ecco-jcc/jjv207.
   PubMed Web of Science ®Google Scholar
• Shyn PB, Mortele KJ, Britz-Cunningham SH, et al. Low-dose 18F-FDG PET/CT enterography: improving on CT enterography assessment of patients with Crohn disease. J Nucl Med. 2010;51(12):1841–1848. doi: 10.2967/jnumed.110.080796.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kumar R, Gupta P, et al. FDG-PET–CT enterography helps determine clinical significance of suspected ileocecal thickening: a prospective study. Dig Dis Sci. 2021;66(5):1620–1630. doi: 10.1007/s10620-020-06361-9.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Li Q, Muller K, et al. Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn’s disease. Inflamm Bowel Dis. 2010;16(6):974–981. doi: 10.1002/ibd.21153.
   PubMed Web of Science ®Google Scholar
• Das CJ, Makharia G, Kumar R, et al. PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine. Eur J Nucl Med Mol Imaging. 2007;34(12):2106–2114. doi: 10.1007/s00259-007-0525-z.
   PubMed Web of Science ®Google Scholar
• Glaudemans AW, de Vries EF, Galli F, et al. The use of F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013;2013:623036–623014. doi: 10.1155/2013/623036.
   PubMedGoogle Scholar
• Lapp RT, Spier BJ, Perlman SB, et al. Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease. Mol Imaging Biol. 2011;13(3):573–576. doi: 10.1007/s11307-010-0367-0.
   PubMed Web of Science ®Google Scholar
• Spier BJ, Perlman SB, Jaskowiak CJ, et al. PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment. Mol Imaging Biol. 2010;12(1):85–88. doi: 10.1007/s11307-009-0232-1.
   PubMed Web of Science ®Google Scholar
• Catalano OA, Wu V, Mahmood U, et al. Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease. Am J Nucl Med Mol Imaging. 2018;8(1):62.
   PubMedGoogle Scholar
• Catalano OA, Gee MS, Nicolai E, et al. Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in Crohn disease. Radiology. 2016;278(3):792–800. doi: 10.1148/radiol.2015150566.
   PubMed Web of Science ®Google Scholar
• Maccioni F, Patak MA, Signore A, et al. New frontiers of MRI in Crohn’s disease: motility imaging, diffusion-weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging. 2012;37(6):974–982. doi: 10.1007/s00261-012-9890-6.
   PubMedGoogle Scholar
• Bhattaru A, Borja A, Zhang V, et al. FDG-PET/CT as the superior imaging modality for inflammatory bowel disease. JNucl Med. 2020;61(1):1159.
   Google Scholar
• Perlman SB, Hall BS, Reichelderfer M, editors. PET/CT imaging of inflammatory bowel disease. Semin Nucl Med. 2013;43(6):420–426. doi: 10.1053/j.semnuclmed.2013.06.006.
   Google Scholar
• Borhani A, Afyouni S, Attari MMA, et al. PET/MR ­enterography in inflammatory bowel disease: a review of applications and technical considerations. Eur J Radiol. 2023;163:110846. doi: 10.1016/j.ejrad.2023.110846.
   PubMed Web of Science ®Google Scholar
• Domachevsky L, Leibovitzh H, Avni-Biron I, et al. Correlation of 18F-FDG PET/MRE metrics with inflammatory biomarkers in patients with Crohn’s disease: a pilot study. Contrast Media Mol Imaging. 2017;2017:7167292–7167299. doi: 10.1155/2017/7167292.
   PubMedGoogle Scholar
• Li Y, Langhorst J, Koch AK, et al. Assessment of ileocolonic inflammation in Crohn’s disease: which surrogate marker is better—MaRIA, Clermont, or PET/MR index? Initial results of a feasibility trial. J Nucl Med. 2019;60(6):851–857. doi: 10.2967/jnumed.118.216937.
   PubMed Web of Science ®Google Scholar
• Freitag MT, Fenchel M, Bäumer P, et al. Improved clinical workflow for simultaneous whole-body PET/MRI ­using high-resolution CAIPIRINHA-accelerated MR-based attenuation correction. Eur J Radiol. 2017;96:12–20. doi: 10.1016/j.ejrad.2017.09.007.
   PubMed Web of Science ®Google Scholar
• Kusmirek JE, Magnusson JD, Perlman SB. Current applications for nuclear medicine imaging in pulmonary disease. Curr Pulmonol Rep. 2020;9(3):82–95. doi: 10.1007/s13665-020-00251-1.
   PubMed Web of Science ®Google Scholar
• Désogère P, Montesi SB, Caravan P. Molecular probes for imaging fibrosis and fibrogenesis. Chemistry. 2019;25(5):1128–1141. doi: 10.1002/chem.201801578.
   PubMed Web of Science ®Google Scholar
• Luo Q, Shao N, Zhang A-C, et al. Smart biomimetic nanozymes for precise molecular imaging: application and challenges. Pharmaceuticals. 2023;16(2):249. doi: 10.3390/ph16020249.
   Web of Science ®Google Scholar
• Wang J, Lin S, Brown JM, et al. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev. 2021;302(1):211–227. doi: 10.1111/imr.12974.
   PubMed Web of Science ®Google Scholar
• Chen W, Lu C, Hirota C, et al. Smooth muscle hyperplasia/hypertrophy is the most prominent histological change in Crohn’s fibrostenosing bowel strictures: a semiquantitative analysis by using a novel histological grading scheme. J Crohns Colitis. 2017;11(1):92–104. doi: 10.1093/ecco-jcc/jjw126.
   PubMed Web of Science ®Google Scholar
• Welz L, Aden K. Fibrosis and inflammation in inflammatory bowel disease—more than 2 sides of the same coin? Gastroenterology. 2023;164(1):19–21. doi: 10.1053/j.gastro.2022.10.024.
   PubMed Web of Science ®Google Scholar
• Li Z, Lu B, Lin J, et al. A type I collagen-targeted mr imaging probe for staging fibrosis in crohn’s disease. Front Mol Biosci. 2021;8:762355. doi: 10.3389/fmolb.2021.762355.
   PubMed Web of Science ®Google Scholar
• Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet. 2001;2(1):343–372. doi: 10.1146/annurev.genom.2.1.343.
   PubMedGoogle Scholar
• Li C, Kuemmerle JF. Mechanisms that mediate the ­development of fibrosis in patients with Crohn’s disease. Inflamm Bowel Dis. 2014;20(7):1250–1258. doi: 10.1097/MIB.0000000000000043.
   PubMed Web of Science ®Google Scholar
• Johnson LA, Rodansky ES, Sauder KL, et al. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis. 2013;19(5):891–903. doi: 10.1097/MIB.0b013e3182813297.
   PubMed Web of Science ®Google Scholar
• Sofias AM, De Lorenzi F, Peña Q, et al. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Adv Drug Deliv Rev. 2021;175:113831. doi: 10.1016/j.addr.2021.113831.
   PubMed Web of Science ®Google Scholar
• Santacroce G, Lenti MV, Di Sabatino A. Therapeutic targeting of intestinal fibrosis in crohn’s disease. Cells. 2022;11(3):429. doi: 10.3390/cells11030429.
   PubMed Web of Science ®Google Scholar
• Poggioli G, Pierangeli F, Laureti S, et al. Indication and type of surgery in Crohn’s disease. Aliment Pharmacol Ther. 2002;16 Suppl 4(s4):59–64. doi: 10.1046/j.1365-2036.16.s4.9.x.
   PubMedGoogle Scholar
• Farmer RG, Hawk WA, TurnbullJrRB. Indications for surgery in Crohn’s disease: analysis of 500 cases. Gastroenterology. 1976;71(2):245–250. doi: 10.1016/S0016-5085(76)80196-5.
   PubMed Web of Science ®Google Scholar
• James S, Tyrrell-Price J. Commentary: PET/MR versus PET/CT imaging: impact on the clinical management of small-bowel crohn’s disease. Front Med. 2017;4:59. doi: 10.3389/fmed.2017.00059.
   Web of Science ®Google Scholar
• Colombel J-F, D’haens G, Lee W-J, et al. Outcomes and strategies to support a treat-to-target approach in ­inflammatory bowel disease: a systematic review. J Crohns Colitis. 2020;14(2):254–266. doi: 10.1093/ecco-jcc/jjz131.
   PubMed Web of Science ®Google Scholar
• Saji H. In vivo molecular imaging. Biol Pharm Bull. 2017;40(10):1605–1615. doi: 10.1248/bpb.b17-00505.
   PubMed Web of Science ®Google Scholar
• Noriega-Álvarez E, Martín-Comín J, editors. Molecular imaging in inflammatory bowel disease. Semin Nucl Med. 2023. doi: 10.1053/j.semnuclmed.2022.12.003.
   Google Scholar
• Le Fur M, Zhou IY, Catalano O, et al. Toward molecular imaging of intestinal pathology. Inflamm Bowel Dis. 2020;26(10):1470–1484. doi: 10.1093/ibd/izaa213.
   PubMedGoogle Scholar
• Rieder F, de Bruyn JR, Pham BT, et al. Results of the 4th scientific workshop of the ECCO (group II): markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis. 2014;8(10):1166–1178. doi: 10.1016/j.crohns.2014.03.009.
   PubMed Web of Science ®Google Scholar
• Latella G, Rieder F. Intestinal fibrosis: ready to be ­reversed. Curr Opin Gastroenterol. 2017;33(4):239–245. doi: 10.1097/MOG.0000000000000363.
   PubMed Web of Science ®Google Scholar
• Scharitzer M, Macher-Beer A, Mang T, et al. Evaluation of intestinal fibrosis with 68Ga-FAPI PET/MR enterography in Crohn disease. Radiology. 2023;307(3):e222389. doi: 10.1148/radiol.222389.
   PubMedGoogle Scholar
• Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn’s disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis. 2012;18(12):2252–2260. doi: 10.1002/ibd.22930.
   PubMed Web of Science ®Google Scholar
• Alyami AS. The role of radiomics in fibrosis Crohn’s disease: a review. Diagnostics. 2023;13(9):1623. doi: 10.3390/diagnostics13091623.
   Web of Science ®Google Scholar
• Meng J, Luo Z, Chen Z, et al. Intestinal fibrosis classification in patients with Crohn’s disease using CT enterography–based deep learning: comparisons with radiomics and radiologists. Eur Radiol. 2022;32(12):8692–8705. doi: 10.1007/s00330-022-08842-z.
   PubMed Web of Science ®Google Scholar
• Lin S, Lin X, Li X, et al. Making qualitative intestinal stricture quantitative: embracing radiomics in IBD. InflammBowel Dis. 2020;26(5):743–745. doi: 10.1093/ibd/izz197.
   Google Scholar
• Stidham RW, Enchakalody B, Waljee AK, et al. Assessing small bowel stricturing and morphology in Crohn’s disease using semi-automated image analysis. Inflamm Bowel Dis. 2020;26(5):734–742. doi: 10.1093/ibd/izz196.
   PubMedGoogle Scholar
• Mori M, Passoni P, Incerti E, et al. Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer. Radiother Oncol. 2020;153:258–264. doi: 10.1016/j.radonc.2020.07.003.
   PubMed Web of Science ®Google Scholar